Key facts
- This page summarizes Victor F. Ganzi's Form 4/A - Amendment filing for Angion Biomedica Corp. (ELTX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 May 2022, 16:19.
Victor F. Ganzi - 09 Feb 2021 Form 4/A - Amendment Insider Report for Angion Biomedica Corp. (ELTX)
- Reporting relationship
- Director
- Issuer ticker
- ELTX
- Reported as of
- 09 Feb 2021
- Net transaction value
- +$2,493
- SEC form
- 4/A - Amendment
- Accepted by SEC
- 27 May 2022, 16:19:36 UTC
- Original report date
- 11 Feb 2021
- Next SEC filing
- 13 May 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jennifer J. Rhodes, as attorney-in fact for Victor F. Ganzi
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Victor F. Ganzi filed Form 4/A - Amendment for Angion Biomedica Corp. (ELTX) on 27 May 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$2,493.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELTX
transaction
Common Stock
Exercise of in-the-money or at-the-money derivative security
- Transaction value
- $3,950,013
- Shares
- +614,310
- Change %
- +135%
- Price
- $6.43
- Shares after
- 1,069,837
- Date
- 09 Feb 2021
- Ownership
- Direct
ELTX
transaction
Common Stock
Sale
- Transaction value
- $3,947,520
- Shares
- -246,720
- Change %
- -23%
- Price
- $16.00
- Shares after
- 823,117
- Date
- 09 Feb 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ELTX
transaction
Derivative
Warrant to Purchase Common Stock
Exercise of in-the-money or at-the-money derivative security
- Transaction value
- $0
- Shares
- -614,310
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 09 Feb 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 614,310
- Exercise price
- $6.43
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person.